KIT D816F
Gene Variant Detail

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene KIT
Variant D816F
Impact List missense
Protein Effect gain of function
Gene Variant Descriptions KIT D816F lies within the tyrosine kinase domain 2 of the Kit protein (PMID: 17555444). D816F results in constitutive phosphorylation of Kit and activation of Stat3, Mapk, and Akt signaling in cultured cells (PMID: 9990072, PMID: 16397263), and also confers resistance to imatinib in culture (PMID: 16397263).
Associated Drug Resistance Y
Category Variants Paths

KIT mutant KIT act mut KIT D816F

KIT mutant KIT exon17 KIT D816X KIT D816F

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_000222.3
gDNA chr4:g.54733154_54733155delGAinsTT
cDNA c.2446_2447delGAinsTT
Protein p.D816F
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
XM_005265741.1 chr4:g.54733154_54733155delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
NM_000222.3 chr4:g.54733154_54733155delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
NM_001093772.2 chr4:g.54733166_54733167delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
NM_000222 chr4:g.54733154_54733155delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
NM_001093772.1 chr4:g.54733166_54733167delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
NM_001385290.1 chr4:g.54733154_54733155delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
NM_000222.2 chr4:g.54733154_54733155delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
NM_001093772 chr4:g.54733166_54733167delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
XM_005265741 chr4:g.54733154_54733155delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
NM_001385292.1 chr4:g.54733166_54733167delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
XM_017008179 chr4:g.54733166_54733167delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38
XM_017008179.1 chr4:g.54733166_54733167delGAinsTT c.2446_2447delGAinsTT p.D816F RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
KIT D816F Advanced Solid Tumor resistant Imatinib Preclinical - Cell culture Actionable In a preclinical study, transformed cells expressing KIT D816F were resistant to Gleevec (imatinib mesylate) in culture (PMID: 16397263). 16397263
KIT D816F Advanced Solid Tumor predicted - sensitive IDRX-42 Preclinical - Biochemical Actionable In a preclinical study, IDRX-42 inhibited kinase activity of KIT D816F in an vitro assay (PMID: 40018846). 40018846